Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
The Lancet. Infectious Diseases|October 20, 2018
Analysis of the clinical antibacterial and antituberculosis pipelineUrsula Theuretzbacher, Simon Gottwalt, Peter Beyer, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Plos One|August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaRoger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
European Journal of Immunology|July 13, 2002
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivoChristian Lienhardt, Annalisa Azzurri, Amedeo Amedei, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2008
Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosisGraham S Cooke, Sarah J Campbell, Steve Bennett, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 21, 2007
Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The GambiaDolly Jackson-Sillah, Philip C Hill, Annette Fox, et al.
The Lancet. Infectious Diseases|February 14, 2012
Is operational research delivering the goods? The journey to success in low-income countriesRony Zachariah, Nathan Ford, Dermot Maher, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 26, 2015
First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in GuineaMebrat Ejo, Florian Gehre, Mamadou Dian Barry, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
The Lancet. Infectious Diseases|October 20, 2018
Analysis of the clinical antibacterial and antituberculosis pipelineUrsula Theuretzbacher, Simon Gottwalt, Peter Beyer, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Plos One|August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaRoger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
European Journal of Immunology|July 13, 2002
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivoChristian Lienhardt, Annalisa Azzurri, Amedeo Amedei, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2008
Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosisGraham S Cooke, Sarah J Campbell, Steve Bennett, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 21, 2007
Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The GambiaDolly Jackson-Sillah, Philip C Hill, Annette Fox, et al.
The Lancet. Infectious Diseases|February 14, 2012
Is operational research delivering the goods? The journey to success in low-income countriesRony Zachariah, Nathan Ford, Dermot Maher, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 26, 2015
First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in GuineaMebrat Ejo, Florian Gehre, Mamadou Dian Barry, et al.
Pageof 12